NanoVibronix, Inc. (NAOV)
NAOV moved a median of -0.40% 30 minutes after news, and -1.48% by the close. How NAOV actually reacts to news — the realized, point-in-time move the market made, measured across 161 labeled events over the last three years with zero look-ahead.
NAOV’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 40% | 139 |
| 30-min | -0.40% | 39% | 146 |
| 60-min | 0.00% | 45% | 152 |
| to close | -1.48% | 34% | 152 |
| Middle 50% of NAOV reactions | -3.33% to +1.72% |
|---|---|
| Median reaction (30-min) | -0.40% |
| Measured reactions | 161 |
Half of all NanoVibronix, Inc. news events land between -3.33% and +1.72% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when NAOV moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to NAOV's baseline. Nothing else.
Recent NAOV events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K ENvue Medical, Inc. For: Dec 17 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form EFFECT ENvue Medical, Inc. | SEC filing · Form EFFECT | SEC EDGAR | — | — | |
| ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK | Press release | GlobeNewswire | — | — | |
| ENvue Medical’s UroShield® Kit Secures Reimbursement in the UK | Press release | GlobeNewswire | — | — | |
| Form 8-K NanoVibronix, Inc. For: Dec 08 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED’ | Press release | Business Wire | — | — | |
| Form S-3/A NanoVibronix, Inc. | SEC filing · Form S-3 | SEC EDGAR | -0.66% | -4.86% | |
| Form 8-K NanoVibronix, Inc. For: Dec 04 | SEC filing · Form 8-K | SEC EDGAR | +1.58% | +0.97% | |
| Form 8-K NanoVibronix, Inc. For: Nov 19 | SEC filing · Form 8-K | SEC EDGAR | -4.07% | -5.74% | |
| NanoVibronix Issues Letter to Shareholders | Press release | Business Wire | -4.07% | -5.74% | |
| Form 10-Q NanoVibronix, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +2.58% | -1.11% | |
| Form ARS NanoVibronix, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +2.15% | +1.08% | |
| Form DEF 14A NanoVibronix, Inc. For: Nov 10 | SEC filing · Form DEF | SEC EDGAR | +2.15% | +1.08% | |
| Form 8-K NanoVibronix, Inc. For: Oct 30 | SEC filing · Form 8-K | SEC EDGAR | -0.57% | -2.84% | |
| Form PRE 14A NanoVibronix, Inc. For: Oct 30 | SEC filing · Form PRE | SEC EDGAR | -0.57% | -2.84% | |
| Form S-3/A NanoVibronix, Inc. | SEC filing · Form S-3 | SEC EDGAR | +1.37% | +1.66% | |
| NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities | Press release | Business Wire | +2.78% | -1.47% | |
| Form 8-K NanoVibronix, Inc. For: Sep 16 | SEC filing · Form 8-K | SEC EDGAR | +2.78% | -1.47% | |
| NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | Press release | Business Wire | -8.60% | -8.60% | |
| Form S-3 NanoVibronix, Inc. | SEC filing · Form S-3 | SEC EDGAR | +1.00% | -15.00% | |
| NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical’s Intellectual Property Portfolio | Press release | Business Wire | +7.25% | +14.07% | |
| NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology | Press release | Business Wire | -4.52% | -4.58% | |
| Form 10-Q NanoVibronix, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -2.71% | |
| Form 8-K NanoVibronix, Inc. For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -10.26% | |
| Form NT 10-Q NanoVibronix, Inc. For: Jun 30 | SEC filing · Form NT | SEC EDGAR | +0.00% | -10.26% | |
| Form 8-K NanoVibronix, Inc. For: Aug 08 | SEC filing · Form 8-K | SEC EDGAR | -0.37% | -0.68% | |
| NanoVibronix Announces Reverse Stock Split | Press release | Business Wire | -2.04% | +8.86% | |
| Form 8-K NanoVibronix, Inc. For: Jul 24 | SEC filing · Form 8-K | SEC EDGAR | -1.20% | -2.81% | |
| Form 8-K NanoVibronix, Inc. For: Jul 18 | SEC filing · Form 8-K | SEC EDGAR | +1.22% | +5.44% | |
| Form 8-K NanoVibronix, Inc. For: Jul 17 | SEC filing · Form 8-K | SEC EDGAR | -0.99% | -1.83% | |
| NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock | Press release | Business Wire | +3.00% | +1.00% | |
| Form 8-K NanoVibronix, Inc. For: Jul 11 | SEC filing · Form 8-K | SEC EDGAR | +1.02% | +1.07% | |
| Form 8-K NanoVibronix, Inc. For: Jul 08 | SEC filing · Form 8-K | SEC EDGAR | +2.01% | +2.30% | |
| NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation | Press release | Business Wire | +1.15% | -0.10% | |
| Form DEFA14A NanoVibronix, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +1.15% | -0.10% | |
| NanoVibronix’s ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement | Press release | Business Wire | +0.50% | +0.03% | |
| Form DEF 14A NanoVibronix, Inc. For: Jun 20 | SEC filing · Form DEF | SEC EDGAR | +0.44% | -3.19% | |
| ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System | Press release | Business Wire | +14.95% | +12.15% | |
| Form PRE 14A NanoVibronix, Inc. For: Jun 09 | SEC filing · Form PRE | SEC EDGAR | -0.56% | -5.41% | |
| Form 8-K NanoVibronix, Inc. For: Jun 04 | SEC filing · Form 8-K | SEC EDGAR | +2.93% | -5.87% | |
| NanoVibronix Announces CEO Transition | Press release | Business Wire | -4.25% | -1.89% | |
| Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures | Press release | Business Wire | -2.54% | -27.49% | |
| NanoVibronix Responds to False Post | Press release | Business Wire | -4.03% | +0.81% | |
| Form 10-Q NanoVibronix, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.59% | -5.60% | |
| Form 8-K NanoVibronix, Inc. For: May 12 | SEC filing · Form 8-K | SEC EDGAR | +1.53% | -0.76% | |
| NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants | Press release | Business Wire | +1.53% | -0.76% | |
| Form EFFECT NanoVibronix, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +3.30% | -1.38% | |
| Form NT 10-Q NanoVibronix, Inc. For: Mar 31 | SEC filing · Form NT | SEC EDGAR | -5.21% | -14.58% | |
| NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants | Press release | Business Wire | +3.30% | -1.38% | |
| Form S-1/A NanoVibronix, Inc. | SEC filing · Form S-1 | SEC EDGAR | -0.26% | -0.78% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the NAOV section they belong to.
Where else NAOV is measured.
NAOV earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NanoViricides, Inc. (NNVC) | 164 | +0.01% | 52% |
| Matinas Biopharma Holdings, Inc. (MTNB) | 161 | -0.53% | 39% |
| Zomedica Corp. Common Shares (ZOM) | 161 | +0.08% | 53% |
| AVITA MEDICAL (AVMXY) | 160 | 0.00% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is NanoVibronix, Inc.'s median reaction calculated?
Every labeled NAOV news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 161 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 39% of NAOV's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does NAOV's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.